DNA Development ApS: Financial statements 2022
CVR: 35842470
DNA Development ApS (CVR 35842470) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK 90,337 and a net result of DKK 78,871 compared with DKK -19,683 the year before. Equity amounted to DKK 501,048. The solvency ratio was 38%.
- Gross Profit
- 90,337 kr.
- Profit/Loss
- 78,871 kr.
- Equity
- 501,048 kr.
- Total Assets
- 1,317,744 kr.
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | - | 90 t. | 79 t. | 501 t. | - |
| 2021 | - | -14 t. | -20 t. | 422 t. | - |
| 2020 | - | -33 t. | -37 t. | -8 t. | - |
| 2019 | - | -32 t. | -36 t. | 29 t. | - |
| 2018 | - | -84 t. | -91 t. | 65 t. | - |
Keep an eye on DNA Development ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
As of September 15, 2022, Jan Jensen is registered as director of DNA Development ApS.
As of September 15, 2022, JN Invest ApS is registered as an owner of DNA Development ApS with an ownership share of 100%.
DNA Development ApS has published its annual report for 2021. Gross profit came to DKK -13,941, and the net result was DKK -19,683.
About DNA Development ApS
DNA Development ApS is a Danish company of the type Anpartsselskab based in Kolding, founded in 2014. The company is registered under the industry Investering for egen regning. The management consists of Jan Jensen and Henrik Skaarup Nielsen. The company is owned by JN Invest ApS. In 2025, the company reported a gross profit of DKK -14,229 and a net result of DKK -24,766 compared with DKK -18,339 the year before. Equity amounted to DKK 471,984.
